<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Investment on FinanClub</title>
    <link>https://finan.club/tags/investment/</link>
    <description>Recent content in Investment on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 04:54:38 +0000</lastBuildDate><atom:link href="https://finan.club/tags/investment/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GSK</title>
      <link>https://finan.club/us/gsk/</link>
      <pubDate>Mon, 11 Sep 2023 04:54:38 +0000</pubDate>
      
      <guid>https://finan.club/us/gsk/</guid>
      <description>score:-20
Chances: GSK&amp;rsquo;s value is being questioned, but it may be undervalued, making it an attractive investment option. GSK announces availability of AREXVY, its Respiratory Syncytial Virus (RSV) vaccine, at all major US retail pharmacies. Settling the first Zantac cancer lawsuit could soothe investors and impact GSK&amp;rsquo;s stock positively.</description>
    </item>
    
    <item>
      <title>NU</title>
      <link>https://finan.club/us/nu/</link>
      <pubDate>Sat, 02 Sep 2023 02:49:07 +0000</pubDate>
      
      <guid>https://finan.club/us/nu/</guid>
      <description>score:-18
Chances: Implied Volatility Surging for Nu Holdings (NU) Stock Options This Unstoppable Fintech Keeps Crushing Analyst Estimates Nu Holdings Ltd. (NU) Surpasses Q2 Earnings and Revenue Estimates Buffett-Backed Nubank Bets on Mexico for ‘Pivotal’ Growth Wall Street Bulls Look Optimistic About Nu Holdings Ltd.</description>
    </item>
    
  </channel>
</rss>
